Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry

Modern Pathology

Volumn 15, Issue 12, 2002, Pages 1374-1380

  Hsu, Forrest D ^a   Nielsen, Torsten O ^a   Alkushi, Abdulmohsen ^a   Dupuis, Bev ^a   Huntsman, David ^a   Long Liu, Chih ^b   De Rijn, Matt van ^c   Gilks, C Blake ^b,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b STANFORD UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Clustering analysis; Immunohistochemistry; Quality assurance; Tissue microarray

Indexed keywords

ALKALINE PHOSPHATASE PLACENTA ISOENZYME; B7 ANTIGEN; CD68 ANTIGEN; CD99 ANTIGEN; CYTOKERATIN; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 20; CYTOKERATIN 22; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 7; CYTOKERATIN 8; EPITHELIAL MEMBRANE ANTIGEN; ESTROGEN RECEPTOR; MELAN A; PROTEIN P53; PROTEIN S 100; SYNAPTOPHYSIN; THYROID TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG; VIMENTIN;

ANTIBODY DETECTION; ANTIGEN DETECTION; ANTIGEN SPECIFICITY; ARTICLE; CLUSTER ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DNA MICROARRAY; HEALTH CARE QUALITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LABORATORY DIAGNOSIS; PRIORITY JOURNAL; STAINING; TISSUE MICROARRAY; TISSUE SPECIFICITY;

CLUSTER ANALYSIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HISTOCYTOLOGICAL PREPARATION TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MALE; NEOPLASMS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; S100 PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036901655     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000039571.02827.CE     Document Type: Article

References (19)

1. Seidal T, Balaton AJ, Battifora H. Interpretation and quantification of immunostains. Am J Surg Pathol 2001;25:1204-7.
2. Wick MR, Mills SE. Consensual interpretive guidelines for diagnostic immunohistochemistry. Am J Surg Pathol 2001; 25:1208-10.
3. Kononen J, Bubendorf L Kallioniemi A, Barlund M, Schraml P, Leighton S, et al. Tissue microarray for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-7.
4. Parker RL, Huntsman DG, Lesack DW, Cupples JB, Grant DR, Akbari M, et al. Assessment of inter-laboratory variation in the immunohistochemical determination of estrogen receptor using a breast cancer tissue microarmy. Am J Clin Pathol (in press).
5. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95:14863-8.
6. Liu CL, Prapong W, Natkuman Y, Alizadeh A, Montgomery K, Gilks CB, et al. Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. Am J Pathol (in press).
7. Green R, Epstein JI. Use of intervening unstained slides for immunohistochemical stains for high molecular weight cytokeratin on prostate needle biopsies. Am J Surg Pathol 1999;23:567-70.
8. Goldstein NS, Underhill J, Roszka J, Neill JS. Cytokeratin 34 beta E-12 immunoreactivity in benign prostatic acini. Quantitation, pattern assessment, and electron microscopic study. Am J Clin Pathol 1999;112:69-74.
9. Iczkowski KA, Cheng L. Crawford BG, Bostwick DG. Steam heat with an EDTA buffer and protease digestion optimizes immunohistochemical expression of basal cell-specific antikeratin 34betaE12 to discriminate cancer in prostatic epithelium. Mod Pathol 1999;12:1-4.
10. Izquierdo MA, Van der Valk P, Van Ark-Otte J, Rubio G, Germa-Lluch JR, Ueda R, et al. Differential expression of the c-kit proto-oncogene in germ cell tumours. J Pathol 1995; 177:253-8.
11. Moch H, Kononen J, Kallioniemi OP, Sauter G. Tissue microarrays: What will they bring to molecular and anatomic pathology? Adv Anat Pathol 2001;8:14-20.
12. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000; 80:1943-9.
13. Nocito A, Bubendorf NA, Maria Tinner E, Suess K, Wagner U, Forster T, et al. Microarrays of bladder cancer tissue are highly representative of proliferative index and histological grade. J Pathol 2001;194:349-57.
14. Torhorst J, Bucher C, Kononen J, Haas P, Zuber M, Kochli OR, et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 2001;159:2249-56.
15. Chu PG, Weiss LM. Expression of cytokeratin 5/6 in epithelial neoplasms: An immunohistochemical study of 509 cases. Mod Pathol 2002;15:6-10.
16. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403: 503-11.
17. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature 2000;406:747-52.
18. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001;98:10869-74.
19. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, et al. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 1999;286:531-7.